APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Solutions

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Selected research

Market Analysis & Forecast

Global Intravenous Solutions Market Analysis and Forecast 2026-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchIntravenous Solutions Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Solutions Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Intravenous Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Solutions Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Solutions Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.

Read the full market overview

In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

This report presents an overview of global market for Intravenous Solutions, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Intravenous Solutions, also provides the sales of main regions and countries. Of the upcoming market potential for Intravenous Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intravenous Solutions sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Intravenous Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Intravenous Solutions sales, projected growth trends, production technology, application and end-user industry.

Intravenous Solutions Segment by Company

Baxter

Kelun Group

Fresenius Kabi

Otsuka

ICU Medical

Fresenius Kabi

JW Life Science

B. Braun Melsungen

Intravenous Solutions Segment by Type

Crystalloids

Colloids

Others

Intravenous Solutions Segment by Application

Basic IV Solutions

Nutrient Infusion Solution

Others

Intravenous Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Intravenous Solutions in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Intravenous Solutions manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Solutions sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Intravenous Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Crystalloids Major Manufacturers Table 3. Colloids Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Intravenous Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Basic IV Solutions Major Manufacturers Table 7. Nutrient Infusion Solution Major Manufacturers Table 8. Others Major Manufacturers Table 9. Intravenous Solutions Industry Trends Table 10. Intravenous Solutions Industry Drivers Table 11. Intravenous Solutions Industry Opportunities and Challenges Table 12. Intravenous Solutions Industry Restraints Table 13. Global Intravenous Solutions Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Intravenous Solutions Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Intravenous Solutions Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Intravenous Solutions Revenue Market Share by Region (2021-2026) Table 17. Global Intravenous Solutions Revenue Market Share by Region (2027-2032) Table 18. Global Intravenous Solutions Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 19. Global Intravenous Solutions Sales by Region (2021-2026) & (M Units) Table 20. Global Intravenous Solutions Sales by Region (2027-2032) & (M Units) Table 21. Global Intravenous Solutions Sales Market Share by Region (2021-2026) Table 22. Global Intravenous Solutions Sales Market Share by Region (2027-2032) Table 23. Global Intravenous Solutions Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Intravenous Solutions Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Intravenous Solutions Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Intravenous Solutions Sales Market Share by Manufacturers (2021-2026) Table 27. Global Intravenous Solutions Sales Price (US$/K Unit) of Manufacturers (2021-2026) Table 28. Global Intravenous Solutions Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Intravenous Solutions Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Intravenous Solutions Manufacturers, Product Type & Application Table 31. Global Intravenous Solutions Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Intravenous Solutions by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Intravenous Solutions Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Intravenous Solutions Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Intravenous Solutions Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Intravenous Solutions Revenue Market Share by Type (2021-2026) Table 38. Global Intravenous Solutions Revenue Market Share by Type (2027-2032) Table 39. Global Intravenous Solutions Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 40. Global Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 41. Global Intravenous Solutions Sales by Type (2027-2032) & (M Units) Table 42. Global Intravenous Solutions Sales Market Share by Type (2021-2026) Table 43. Global Intravenous Solutions Sales Market Share by Type (2027-2032) Table 44. Global Intravenous Solutions Price by Type (2021-2026) & (US$/K Unit) Table 45. Global Intravenous Solutions Price by Type (2027-2032) & (US$/K Unit) Table 46. Global Intravenous Solutions Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Intravenous Solutions Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Intravenous Solutions Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Intravenous Solutions Revenue Market Share by Application (2021-2026) Table 50. Global Intravenous Solutions Revenue Market Share by Application (2027-2032) Table 51. Global Intravenous Solutions Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 52. Global Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 53. Global Intravenous Solutions Sales by Application (2027-2032) & (M Units) Table 54. Global Intravenous Solutions Sales Market Share by Application (2021-2026) Table 55. Global Intravenous Solutions Sales Market Share by Application (2027-2032) Table 56. Global Intravenous Solutions Price by Application (2021-2026) & (US$/K Unit) Table 57. Global Intravenous Solutions Price by Application (2027-2032) & (US$/K Unit) Table 58. Baxter Company Information Table 59. Baxter Business Overview Table 60. Baxter Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 61. Baxter Intravenous Solutions Product Portfolio Table 62. Baxter Recent Development Table 63. Kelun Group Company Information Table 64. Kelun Group Business Overview Table 65. Kelun Group Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 66. Kelun Group Intravenous Solutions Product Portfolio Table 67. Kelun Group Recent Development Table 68. Fresenius Kabi Company Information Table 69. Fresenius Kabi Business Overview Table 70. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 71. Fresenius Kabi Intravenous Solutions Product Portfolio Table 72. Fresenius Kabi Recent Development Table 73. Otsuka Company Information Table 74. Otsuka Business Overview Table 75. Otsuka Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 76. Otsuka Intravenous Solutions Product Portfolio Table 77. Otsuka Recent Development Table 78. ICU Medical Company Information Table 79. ICU Medical Business Overview Table 80. ICU Medical Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 81. ICU Medical Intravenous Solutions Product Portfolio Table 82. ICU Medical Recent Development Table 83. Fresenius Kabi Company Information Table 84. Fresenius Kabi Business Overview Table 85. Fresenius Kabi Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 86. Fresenius Kabi Intravenous Solutions Product Portfolio Table 87. Fresenius Kabi Recent Development Table 88. JW Life Science Company Information Table 89. JW Life Science Business Overview Table 90. JW Life Science Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 91. JW Life Science Intravenous Solutions Product Portfolio Table 92. JW Life Science Recent Development Table 93. B. Braun Melsungen Company Information Table 94. B. Braun Melsungen Business Overview Table 95. B. Braun Melsungen Intravenous Solutions Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 96. B. Braun Melsungen Intravenous Solutions Product Portfolio Table 97. B. Braun Melsungen Recent Development Table 98. North America Intravenous Solutions Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Intravenous Solutions Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 101. North America Intravenous Solutions Sales by Type (2027-2032) & (M Units) Table 102. North America Intravenous Solutions Sales Price by Type (2021-2026) & (US$/K Unit) Table 103. North America Intravenous Solutions Sales Price by Type (2027-2032) & (US$/K Unit) Table 104. North America Intravenous Solutions Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Intravenous Solutions Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 107. North America Intravenous Solutions Sales by Application (2027-2032) & (M Units) Table 108. North America Intravenous Solutions Sales Price by Application (2021-2026) & (US$/K Unit) Table 109. North America Intravenous Solutions Sales Price by Application (2027-2032) & (US$/K Unit) Table 110. North America Intravenous Solutions Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Intravenous Solutions Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Intravenous Solutions Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Intravenous Solutions Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 114. North America Intravenous Solutions Sales by Country (2021-2026) & (M Units) Table 115. North America Intravenous Solutions Sales by Country (2027-2032) & (M Units) Table 116. North America Intravenous Solutions Sales Price by Country (2021-2026) & (US$/K Unit) Table 117. North America Intravenous Solutions Sales Price by Country (2027-2032) & (US$/K Unit) Table 118. United States Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 119. Canada Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 120. Mexico Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 121. Europe Intravenous Solutions Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Intravenous Solutions Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 124. Europe Intravenous Solutions Sales by Type (2027-2032) & (M Units) Table 125. Europe Intravenous Solutions Sales Price by Type (2021-2026) & (US$/K Unit) Table 126. Europe Intravenous Solutions Sales Price by Type (2027-2032) & (US$/K Unit) Table 127. Europe Intravenous Solutions Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Intravenous Solutions Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 130. Europe Intravenous Solutions Sales by Application (2027-2032) & (M Units) Table 131. Europe Intravenous Solutions Sales Price by Application (2021-2026) & (US$/K Unit) Table 132. Europe Intravenous Solutions Sales Price by Application (2027-2032) & (US$/K Unit) Table 133. Europe Intravenous Solutions Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Intravenous Solutions Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Intravenous Solutions Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Intravenous Solutions Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 137. Europe Intravenous Solutions Sales by Country (2021-2026) & (M Units) Table 138. Europe Intravenous Solutions Sales by Country (2027-2032) & (M Units) Table 139. Europe Intravenous Solutions Sales Price by Country (2021-2026) & (US$/K Unit) Table 140. Europe Intravenous Solutions Sales Price by Country (2027-2032) & (US$/K Unit) Table 141. Germany Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 142. France Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 143. U.K. Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 144. Italy Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 145. Russia Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 146. Spain Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 149. Sweden Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 150. Poland Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 151. China Intravenous Solutions Revenue by Type (2021-2026) & (US$ Million) Table 152. China Intravenous Solutions Revenue by Type (2027-2032) & (US$ Million) Table 153. China Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 154. China Intravenous Solutions Sales by Type (2027-2032) & (M Units) Table 155. China Intravenous Solutions Sales Price by Type (2021-2026) & (US$/K Unit) Table 156. China Intravenous Solutions Sales Price by Type (2027-2032) & (US$/K Unit) Table 157. China Intravenous Solutions Revenue by Application (2021-2026) & (US$ Million) Table 158. China Intravenous Solutions Revenue by Application (2027-2032) & (US$ Million) Table 159. China Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 160. China Intravenous Solutions Sales by Application (2027-2032) & (M Units) Table 161. China Intravenous Solutions Sales Price by Application (2021-2026) & (US$/K Unit) Table 162. China Intravenous Solutions Sales Price by Application (2027-2032) & (US$/K Unit) Table 163. Asia Intravenous Solutions Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Intravenous Solutions Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 166. Asia Intravenous Solutions Sales by Type (2027-2032) & (M Units) Table 167. Asia Intravenous Solutions Sales Price by Type (2021-2026) & (US$/K Unit) Table 168. Asia Intravenous Solutions Sales Price by Type (2027-2032) & (US$/K Unit) Table 169. Asia Intravenous Solutions Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Intravenous Solutions Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 172. Asia Intravenous Solutions Sales by Application (2027-2032) & (M Units) Table 173. Asia Intravenous Solutions Sales Price by Application (2021-2026) & (US$/K Unit) Table 174. Asia Intravenous Solutions Sales Price by Application (2027-2032) & (US$/K Unit) Table 175. Asia Intravenous Solutions Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Intravenous Solutions Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Intravenous Solutions Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Intravenous Solutions Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 179. Asia Intravenous Solutions Sales by Country (2021-2026) & (M Units) Table 180. Asia Intravenous Solutions Sales by Country (2027-2032) & (M Units) Table 181. Asia Intravenous Solutions Sales Price by Country (2021-2026) & (US$/K Unit) Table 182. Asia Intravenous Solutions Sales Price by Country (2027-2032) & (US$/K Unit) Table 183. Japan Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 184. South Korea Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 185. India Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 186. Australia Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Intravenous Solutions Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Intravenous Solutions Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Intravenous Solutions Sales by Type (2021-2026) & (M Units) Table 192. SAMEA Intravenous Solutions Sales by Type (2027-2032) & (M Units) Table 193. SAMEA Intravenous Solutions Sales Price by Type (2021-2026) & (US$/K Unit) Table 194. SAMEA Intravenous Solutions Sales Price by Type (2027-2032) & (US$/K Unit) Table 195. SAMEA Intravenous Solutions Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Intravenous Solutions Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Intravenous Solutions Sales by Application (2021-2026) & (M Units) Table 198. SAMEA Intravenous Solutions Sales by Application (2027-2032) & (M Units) Table 199. SAMEA Intravenous Solutions Sales Price by Application (2021-2026) & (US$/K Unit) Table 200. SAMEA Intravenous Solutions Sales Price by Application (2027-2032) & (US$/K Unit) Table 201. SAMEA Intravenous Solutions Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Intravenous Solutions Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Intravenous Solutions Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Intravenous Solutions Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 205. SAMEA Intravenous Solutions Sales by Country (2021-2026) & (M Units) Table 206. SAMEA Intravenous Solutions Sales by Country (2027-2032) & (M Units) Table 207. SAMEA Intravenous Solutions Sales Price by Country (2021-2026) & (US$/K Unit) Table 208. SAMEA Intravenous Solutions Sales Price by Country (2027-2032) & (US$/K Unit) Table 209. Brazil Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 210. Argentina Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 211. Chile Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 212. Colombia Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 213. Peru Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 215. Israel Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 216. UAE Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 217. Turkey Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 218. Iran Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 219. Egypt Intravenous Solutions Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Intravenous Solutions Distributors List Table 223. Intravenous Solutions Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Intravenous Solutions Image Figure 2. Global Intravenous Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 4. Crystalloids Image Figure 5. Colloids Image Figure 6. Others Image Figure 7. Global Intravenous Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Intravenous Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 9. Basic IV Solutions Image Figure 10. Nutrient Infusion Solution Image Figure 11. Others Image Figure 12. Global Intravenous Solutions Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Intravenous Solutions Revenue (2021-2032) & (US$ Million) Figure 14. Global Intravenous Solutions Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Intravenous Solutions Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Intravenous Solutions Revenue Market Share by Region (2021-2032) Figure 17. Global Intravenous Solutions Sales (2021-2032) & (M Units) Figure 18. Global Intravenous Solutions Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 19. Global Intravenous Solutions Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Intravenous Solutions Sales YoY (2021-2032) & (M Units) Figure 21. Europe Intravenous Solutions Sales YoY (2021-2032) & (M Units) Figure 22. China Intravenous Solutions Sales YoY (2021-2032) & (M Units) Figure 23. Asia (Excluding China) Intravenous Solutions Sales YoY (2021-2032) & (M Units) Figure 24. South America, Middle East and Africa Intravenous Solutions Sales YoY (2021-2032) & (M Units) Figure 25. Global Intravenous Solutions Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Intravenous Solutions Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Intravenous Solutions Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Intravenous Solutions Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Intravenous Solutions Revenue Market Share by Type (2021-2032) Figure 31. Global Intravenous Solutions Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 32. Global Intravenous Solutions Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Intravenous Solutions Sales Market Share by Type (2021-2032) Figure 34. Global Intravenous Solutions Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Intravenous Solutions Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Intravenous Solutions Revenue Market Share by Application (2021-2032) Figure 37. Global Intravenous Solutions Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 38. Global Intravenous Solutions Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Intravenous Solutions Sales Market Share by Application (2021-2032) Figure 40. North America Intravenous Solutions Revenue Share by Type (2021-2032) Figure 41. North America Intravenous Solutions Sales Share by Type (2021-2032) Figure 42. North America Intravenous Solutions Revenue Share by Application (2021-2032) Figure 43. North America Intravenous Solutions Sales Share by Application (2021-2032) Figure 44. North America Intravenous Solutions Revenue Share by Country (2021-2032) Figure 45. North America Intravenous Solutions Sales Share by Country (2021-2032) Figure 46. Europe Intravenous Solutions Revenue Share by Type (2021-2032) Figure 47. Europe Intravenous Solutions Sales Share by Type (2021-2032) Figure 48. Europe Intravenous Solutions Revenue Share by Application (2021-2032) Figure 49. Europe Intravenous Solutions Sales Share by Application (2021-2032) Figure 50. Europe Intravenous Solutions Revenue Share by Country (2021-2032) Figure 51. Europe Intravenous Solutions Sales Share by Country (2021-2032) Figure 52. China Intravenous Solutions Revenue Share by Type (2021-2032) Figure 53. China Intravenous Solutions Sales Share by Type (2021-2032) Figure 54. China Intravenous Solutions Revenue Share by Application (2021-2032) Figure 55. China Intravenous Solutions Sales Share by Application (2021-2032) Figure 56. Asia Intravenous Solutions Revenue Share by Type (2021-2032) Figure 57. Asia Intravenous Solutions Sales Share by Type (2021-2032) Figure 58. Asia Intravenous Solutions Revenue Share by Application (2021-2032) Figure 59. Asia Intravenous Solutions Sales Share by Application (2021-2032) Figure 60. Asia Intravenous Solutions Revenue Share by Country (2021-2032) Figure 61. Asia Intravenous Solutions Sales Share by Country (2021-2032) Figure 62. SAMEA Intravenous Solutions Revenue Share by Type (2021-2032) Figure 63. SAMEA Intravenous Solutions Sales Share by Type (2021-2032) Figure 64. SAMEA Intravenous Solutions Revenue Share by Application (2021-2032) Figure 65. SAMEA Intravenous Solutions Sales Share by Application (2021-2032) Figure 66. SAMEA Intravenous Solutions Revenue Share by Country (2021-2032) Figure 67. SAMEA Intravenous Solutions Sales Share by Country (2021-2032) Figure 68. Intravenous Solutions Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Intravenous Solutions Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Crystalloids
  • Colloids
  • Others
Applications
  • Basic IV Solutions
  • Nutrient Infusion Solution
  • Others
Companies covered
  • Baxter
  • Kelun Group
  • Fresenius Kabi
  • Otsuka
  • ICU Medical
  • Fresenius Kabi
  • JW Life Science
  • B. Braun Melsungen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Intravenous Solutions Market by Type
  3. 1.2.1 Global Intravenous Solutions Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Crystalloids
  5. 1.2.3 Colloids
  6. 1.2.4 Others
  7. 1.3 Intravenous Solutions Market by Application
  8. 1.3.1 Global Intravenous Solutions Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Basic IV Solutions
  10. 1.3.3 Nutrient Infusion Solution
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Intravenous Solutions Market Dynamics
  1. 2.1 Intravenous Solutions Industry Trends
  2. 2.2 Intravenous Solutions Industry Drivers
  3. 2.3 Intravenous Solutions Industry Opportunities and Challenges
  4. 2.4 Intravenous Solutions Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Intravenous Solutions Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Intravenous Solutions Revenue by Region
  3. 3.2.1 Global Intravenous Solutions Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Intravenous Solutions Revenue by Region (2021-2026)
  5. 3.2.3 Global Intravenous Solutions Revenue by Region (2027-2032)
  6. 3.2.4 Global Intravenous Solutions Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Intravenous Solutions Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Intravenous Solutions Sales by Region
  9. 3.4.1 Global Intravenous Solutions Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Intravenous Solutions Sales by Region (2021-2026)
  11. 3.4.3 Global Intravenous Solutions Sales by Region (2027-2032)
  12. 3.4.4 Global Intravenous Solutions Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Intravenous Solutions Revenue by Manufacturers
  2. 4.1.1 Global Intravenous Solutions Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Intravenous Solutions Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Intravenous Solutions Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Intravenous Solutions Sales by Manufacturers
  6. 4.2.1 Global Intravenous Solutions Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Intravenous Solutions Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Intravenous Solutions Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Intravenous Solutions Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Intravenous Solutions Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Intravenous Solutions Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Intravenous Solutions Manufacturers, Product Type & Application
  13. 4.7 Global Intravenous Solutions Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Intravenous Solutions Market CR5 and HHI
  16. 4.8.2 2025 Intravenous Solutions Tier 1, Tier 2, and Tier 3
5 Intravenous Solutions Market by Type
  1. 5.1 Global Intravenous Solutions Revenue by Type
  2. 5.1.1 Global Intravenous Solutions Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Intravenous Solutions Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Intravenous Solutions Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Intravenous Solutions Sales by Type
  6. 5.2.1 Global Intravenous Solutions Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Solutions Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Intravenous Solutions Sales Market Share by Type (2021-2032)
  9. 5.3 Global Intravenous Solutions Price by Type
6 Intravenous Solutions Market by Application
  1. 6.1 Global Intravenous Solutions Revenue by Application
  2. 6.1.1 Global Intravenous Solutions Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Intravenous Solutions Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Intravenous Solutions Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Intravenous Solutions Sales by Application
  6. 6.2.1 Global Intravenous Solutions Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Intravenous Solutions Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Intravenous Solutions Sales Market Share by Application (2021-2032)
  9. 6.3 Global Intravenous Solutions Price by Application
7 Company Profiles
  1. 7.1 Baxter
  2. 7.1.1 Baxter Company Information
  3. 7.1.2 Baxter Business Overview
  4. 7.1.3 Baxter Intravenous Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Baxter Intravenous Solutions Product Portfolio
  6. 7.1.5 Baxter Recent Developments
  7. 7.2 Kelun Group
  8. 7.2.1 Kelun Group Company Information
  9. 7.2.2 Kelun Group Business Overview
  10. 7.2.3 Kelun Group Intravenous Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Kelun Group Intravenous Solutions Product Portfolio
  12. 7.2.5 Kelun Group Recent Developments
  13. 7.3 Fresenius Kabi
  14. 7.3.1 Fresenius Kabi Company Information
  15. 7.3.2 Fresenius Kabi Business Overview
  16. 7.3.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Fresenius Kabi Intravenous Solutions Product Portfolio
  18. 7.3.5 Fresenius Kabi Recent Developments
  19. 7.4 Otsuka
  20. 7.4.1 Otsuka Company Information
  21. 7.4.2 Otsuka Business Overview
  22. 7.4.3 Otsuka Intravenous Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Otsuka Intravenous Solutions Product Portfolio
  24. 7.4.5 Otsuka Recent Developments
  25. 7.5 ICU Medical
  26. 7.5.1 ICU Medical Company Information
  27. 7.5.2 ICU Medical Business Overview
  28. 7.5.3 ICU Medical Intravenous Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 ICU Medical Intravenous Solutions Product Portfolio
  30. 7.5.5 ICU Medical Recent Developments
  31. 7.6 Fresenius Kabi
  32. 7.6.1 Fresenius Kabi Company Information
  33. 7.6.2 Fresenius Kabi Business Overview
  34. 7.6.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Fresenius Kabi Intravenous Solutions Product Portfolio
  36. 7.6.5 Fresenius Kabi Recent Developments
  37. 7.7 JW Life Science
  38. 7.7.1 JW Life Science Company Information
  39. 7.7.2 JW Life Science Business Overview
  40. 7.7.3 JW Life Science Intravenous Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 JW Life Science Intravenous Solutions Product Portfolio
  42. 7.7.5 JW Life Science Recent Developments
  43. 7.8 B. Braun Melsungen
  44. 7.8.1 B. Braun Melsungen Company Information
  45. 7.8.2 B. Braun Melsungen Business Overview
  46. 7.8.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 B. Braun Melsungen Intravenous Solutions Product Portfolio
  48. 7.8.5 B. Braun Melsungen Recent Developments
8 North America
  1. 8.1 North America Intravenous Solutions Market Size by Type
  2. 8.1.1 North America Intravenous Solutions Revenue by Type (2021-2032)
  3. 8.1.2 North America Intravenous Solutions Sales by Type (2021-2032)
  4. 8.1.3 North America Intravenous Solutions Price by Type (2021-2032)
  5. 8.2 North America Intravenous Solutions Market Size by Application
  6. 8.2.1 North America Intravenous Solutions Revenue by Application (2021-2032)
  7. 8.2.2 North America Intravenous Solutions Sales by Application (2021-2032)
  8. 8.2.3 North America Intravenous Solutions Price by Application (2021-2032)
  9. 8.3 North America Intravenous Solutions Market Size by Country
  10. 8.3.1 North America Intravenous Solutions Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Intravenous Solutions Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Intravenous Solutions Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Intravenous Solutions Market Size by Type
  2. 9.1.1 Europe Intravenous Solutions Revenue by Type (2021-2032)
  3. 9.1.2 Europe Intravenous Solutions Sales by Type (2021-2032)
  4. 9.1.3 Europe Intravenous Solutions Price by Type (2021-2032)
  5. 9.2 Europe Intravenous Solutions Market Size by Application
  6. 9.2.1 Europe Intravenous Solutions Revenue by Application (2021-2032)
  7. 9.2.2 Europe Intravenous Solutions Sales by Application (2021-2032)
  8. 9.2.3 Europe Intravenous Solutions Price by Application (2021-2032)
  9. 9.3 Europe Intravenous Solutions Market Size by Country
  10. 9.3.1 Europe Intravenous Solutions Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Intravenous Solutions Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Intravenous Solutions Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Intravenous Solutions Market Size by Type
  2. 10.1.1 China Intravenous Solutions Revenue by Type (2021-2032)
  3. 10.1.2 China Intravenous Solutions Sales by Type (2021-2032)
  4. 10.1.3 China Intravenous Solutions Price by Type (2021-2032)
  5. 10.2 China Intravenous Solutions Market Size by Application
  6. 10.2.1 China Intravenous Solutions Revenue by Application (2021-2032)
  7. 10.2.2 China Intravenous Solutions Sales by Application (2021-2032)
  8. 10.2.3 China Intravenous Solutions Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Intravenous Solutions Market Size by Type
  2. 11.1.1 Asia Intravenous Solutions Revenue by Type (2021-2032)
  3. 11.1.2 Asia Intravenous Solutions Sales by Type (2021-2032)
  4. 11.1.3 Asia Intravenous Solutions Price by Type (2021-2032)
  5. 11.2 Asia Intravenous Solutions Market Size by Application
  6. 11.2.1 Asia Intravenous Solutions Revenue by Application (2021-2032)
  7. 11.2.2 Asia Intravenous Solutions Sales by Application (2021-2032)
  8. 11.2.3 Asia Intravenous Solutions Price by Application (2021-2032)
  9. 11.3 Asia Intravenous Solutions Market Size by Country
  10. 11.3.1 Asia Intravenous Solutions Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Intravenous Solutions Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Intravenous Solutions Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Intravenous Solutions Market Size by Type
  2. 12.1.1 SAMEA Intravenous Solutions Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Intravenous Solutions Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Intravenous Solutions Price by Type (2021-2032)
  5. 12.2 SAMEA Intravenous Solutions Market Size by Application
  6. 12.2.1 SAMEA Intravenous Solutions Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Intravenous Solutions Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Intravenous Solutions Price by Application (2021-2032)
  9. 12.3 SAMEA Intravenous Solutions Market Size by Country
  10. 12.3.1 SAMEA Intravenous Solutions Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Intravenous Solutions Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Intravenous Solutions Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Intravenous Solutions Value Chain Analysis
  2. 13.1.1 Intravenous Solutions Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Intravenous Solutions Production Mode & Process
  6. 13.2 Intravenous Solutions Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Intravenous Solutions Distributors
  9. 13.2.3 Intravenous Solutions Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst